Dr. Monge’s current research focuses on 1) the development of new therapies for plasma cell disorders, including multiple myeloma; 2) harnessing genomic and epigenomic tools to improve the accuracy of diagnosis, prediction of treatment response and overall prognosis of plasma cell disorders; and 3) reducing outcome disparities in patients with hematologic malignancies by addressing barriers to accessing specialized hematologic care and increasing the representation of ethnic and racial minority groups in clinical trials.

Relationships and collaborations with for-profit and not-for-profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Consultant refers to an individual who provides expert advice to a business or entity (e.g., consulting on medical devices or pharmaceuticals)Consultant:

Janssen Biotech Inc.; Janssen Scientific Affairs, LLC